REHOVOT, Israel, Nov. 15, 2021 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced the launch of Collink.3D, a recombinant human collagen (rhCollagen)- based BioInk solution for use in 3D bioprinting.
PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, announced its SurgiMend® Collagen Matrix for Soft Tissue Reconstruction has received an Innovative Technology contract from Vizient, Inc. the nation’s largest member-driven health care performance improvement company. The contract was awarded based on the recommendation by hospital experts who serve on one of Vizient’s member-led councils, and it signifies to Vizient members the unique qualities of SurgiMend Collagen Matrix that potentially bring improvement to the health care industry.
PALO ALTO, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, announced today that “Collagen VI as a driver and disease biomarker in human fibrosis” has been published in the FEBS Journal as part of their State-of-the-Art Review series.
The Health Regulatory Agency (ANVISA) of the Brazilian Ministry of Health has provided marketing authorisation for Mobilee® as a novel food ingredient in the country. Part of Bioiberica’s branded ingredients portfolio for healthcare, Mobilee® is a patented ingredient derived from rooster comb extract that is rich in hyaluronic acid. Proven to contribute to maintaining joint health and muscular function, Mobilee®contains a high concentration of hyaluronic acid and other components, including collagen and polysaccharides. Its nutritional characteristics and safety have been tested in six preclinical trials and five randomised clinical trials over the last twelve years. Now available for use in food applications across Brazil, manufacturers across the country are able to meet growing consumer demand for products that support joint health and mobility.